When assessing the impact of RPA expression on the survival of GBM patients only, Kaplan-Meier survival analysis showed that high expresion of RPA70 and RPA14, but not RPA32, informs worse patient survival (Supplementary Figure S2A). The gene discussed is RPA3; the disease is glioblastoma.